536 Followers on Owler

Kronos Bio

is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer... Read more
OverviewCompetitorsFundingNews & Insights

Kronos Bio

is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer... Read more
Kronos Bio Interim-CEO: Deborah Knobelman

Interim-CEO

Deborah Knobelman

CEO Approval Rating

- -/100

2017

PublicIndependent CompanyNASDAQKRON

Pharmaceuticals & Biotechnology
BiotechnologyPharmaceuticals
2836 NAICS listing

Annual Revenue
$9.8M
Employees
100
Funding
$521M

News

Leadership Change
Dec 07, 2024
Bizjournals
Deborah Knobelman is now Interim-CEO at Kronos Bio

Kronos Bio Competitors

1ImmunoGenesis
2Aura
3Perthera
4Rexahn
5Cantex Pharmaceuticals, Inc.
6Polaris
7PNP Therapeutics
8Plexium
9Silverback Therapeutics
10Jounce
See 12+ competitors

Trending Companies